EpiPen Price Increases
The chief executive officer of Mylan testified at a hearing on her company’s price increase on its EpiPen, an anti-anaphylaxis injection… read more
The chief executive officer of Mylan testified at a hearing on her company’s price increase on its EpiPen, an anti-anaphylaxis injection medication. Lawmakers from both parties questioned Heather Bresch on the reasons for the price increase, which totaled more than 500 percent over a seven-year period. She defended the price increases, saying the company has boosted EpiPen’s availability to consumers of all means, and to public schools. The deputy director of the Food and Drug administration also appeared at the hearing. close
People in this video
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Doug Throckmorton M.D. Deputy Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Hosting Organization
Series
Related Video
-
2016 Hearings in Review
Portions of four notable House and Senate hearings of 2016 were shown: The March 17, 2016, House hearing “Flint, Michigan Drinking Water Contamination”…
-
Airline Customer Service
Airline industry executives, including United Airlines CEO Oscar Munoz, testified at a hearing on customer service…
-
Acting CFPB Director Mulvaney News Conference
Mick Mulvaney, the acting Consumer Financial Protection Bureau (CFPB) director, addressed the press and took questions…
-
David Mitchell on Prescription Drug Costs
David Mitchell talked about efforts by his Patients For Affordable Drugs organization to lower prescription drug prices.